METHOD OF PREVENTING ANTENATAL FETUS INFECTION Russian patent published in 2014 - IPC A61K31/00 A61K38/24 A61P17/00 A61P31/22 

FIELD: medicine.

SUBSTANCE: invention relates to field of medicine, namely to obstetrics and gynecology, and can be applied for prevention of antenatal infection of fetus by herpes simplex virus. For this purpose local and system episodic treatment with Acyclovir is carried out in case of herpetic infection relapse. In addition, antihomotoxic therapy is carried out by medicine Engistol for three months at pregravidal stage in women infected by virus herpes simplex. Dose of intake for the first month is 1 pill 3 times per day, for the second month - 1 pill 2 times per day, third month - 1 pill 1 time per day; and in the period of gestation in form of tree courses of antihomotoxic therapy by medication Engistol in dose 1 pill 3 times per day in terms 14-18 weeks, 24-28 weeks, 34-38 weeks of pregnancy.

EFFECT: method is non-invasive, safe for the health of pregnant woman and fetus, available for institution of obstetrics, increases efficiency of prevention of antenatal fetus infection.